Cardon Lon
SEC insider (Form 3/4/5 filer). CIK 0001854337. Director at Mirum Pharmaceuticals, Inc. (MIRM). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in FOSTER CITY, CA.
Companies Cardon Lon has filed insider reports for
- Mirum Pharmaceuticals, Inc. (MIRM): Director
Cardon Lon
CIK: 0001854337
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Mirum Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
3.8K shares- - Jun 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
2K shares- - May 29, 2026MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect4K shares- - May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
ExerciseDirect5.7K shares- - May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
6.3K shares- - May 29, 2025MIRM
Mirum Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 3,772 | - | - | Direct |
| Jun 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award Restricted Stock Units | 1,980 | - | - | Direct |
| May 29, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 3,977 | - | $0 | Direct |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Exercise | 5,703 | - | - | Direct |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 6,268 | - | - | Direct |
| May 29, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Award Restricted Stock Units | 3,977 | - | - | Direct |
1-6 of 6 transactions